日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Picrophilus torridus 50S ribosomal protein L3P (rpl3p) CSB-YP753789PAAB
CSB-EP753789PAAB
CSB-BP753789PAAB
CSB-MP753789PAAB
CSB-EP753789PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus UPF0095 protein PTO0617 (PTO0617) CSB-YP753790PAAB
CSB-EP753790PAAB
CSB-BP753790PAAB
CSB-MP753790PAAB
CSB-EP753790PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus Ribose-5-phosphate isomerase A (rpiA) CSB-YP753791PAAB
CSB-EP753791PAAB
CSB-BP753791PAAB
CSB-MP753791PAAB
CSB-EP753791PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus Probable octanoyltransferase 1 (lipB1) CSB-YP753792PAAB
CSB-EP753792PAAB
CSB-BP753792PAAB
CSB-MP753792PAAB
CSB-EP753792PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus TATA-box-binding protein (tbp) CSB-YP753793PAAB
CSB-EP753793PAAB
CSB-BP753793PAAB
CSB-MP753793PAAB
CSB-EP753793PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus Lysine--tRNA ligase (lysS), partial CSB-YP753794PAAB
CSB-EP753794PAAB
CSB-BP753794PAAB
CSB-MP753794PAAB
CSB-EP753794PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus Elongation factor 1-alpha (tuf) CSB-YP753795PAAB
CSB-EP753795PAAB
CSB-BP753795PAAB
CSB-MP753795PAAB
CSB-EP753795PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus UPF0219 protein PTO0384 (PTO0384) CSB-YP753796PAAB
CSB-EP753796PAAB
CSB-BP753796PAAB
CSB-MP753796PAAB
CSB-EP753796PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus Anthranilate phosphoribosyltransferase (trpD) CSB-YP753797PAAB
CSB-EP753797PAAB
CSB-BP753797PAAB
CSB-MP753797PAAB
CSB-EP753797PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus 50S ribosomal protein L18e (rpl18e) CSB-YP753798PAAB
CSB-EP753798PAAB
CSB-BP753798PAAB
CSB-MP753798PAAB
CSB-EP753798PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus Translation initiation factor 6 (eif6) CSB-YP753799PAAB
CSB-EP753799PAAB
CSB-BP753799PAAB
CSB-MP753799PAAB
CSB-EP753799PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus Adenylosuccinate synthetase (purA) CSB-YP753800PAAB
CSB-EP753800PAAB
CSB-BP753800PAAB
CSB-MP753800PAAB
CSB-EP753800PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picrophilus torridus Alpha-1,4-glucan:maltose-1-phosphate maltosyltransferase (glgE), partial CSB-YP753801PAAB
CSB-EP753801PAAB
CSB-BP753801PAAB
CSB-MP753801PAAB
CSB-EP753801PAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum hybrid Photosystem II reaction center protein T (psbT), partial CSB-YP753802SAN
CSB-EP753802SAN
CSB-BP753802SAN
CSB-MP753802SAN
CSB-EP753802SAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum hybrid Cytochrome b559 subunit beta (psbF), partial CSB-YP753803SAN
CSB-EP753803SAN
CSB-BP753803SAN
CSB-MP753803SAN
CSB-EP753803SAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum hybrid Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP753804SAN
CSB-EP753804SAN
CSB-BP753804SAN
CSB-MP753804SAN
CSB-EP753804SAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum hybrid NAD (P)H-quinone oxidoreductase subunit J, chloroplastic (ndhJ) CSB-YP753805SAN
CSB-EP753805SAN
CSB-BP753805SAN
CSB-MP753805SAN
CSB-EP753805SAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum hybrid Cytochrome b6-f complex subunit 8 (petN), partial CSB-YP753806SAN
CSB-EP753806SAN
CSB-BP753806SAN
CSB-MP753806SAN
CSB-EP753806SAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum hybrid 50S ribosomal protein L2, chloroplastic (rpl2-A) CSB-YP753807SAN
CSB-EP753807SAN
CSB-BP753807SAN
CSB-MP753807SAN
CSB-EP753807SAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum hybrid Uncharacterized protein ycf76 (ycf76-A) CSB-YP753808SAN
CSB-EP753808SAN
CSB-BP753808SAN
CSB-MP753808SAN
CSB-EP753808SAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×